Home
>
National Drug Code (NDC)
>
Thalomid
Thalomid - 59572-205-97 - (Thalidomide)
Drug Information of Thalomid
| Product NDC: | 59572-205 |
| Proprietary Name: | Thalomid |
| Non Proprietary Name: | Thalidomide |
| Active Ingredient(s): | 50 mg/1 & nbsp; Thalidomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Thalomid
| Product NDC: | 59572-205 |
| Labeler Name: | Celgene Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020785 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030620 |
Package Information of Thalomid
| Package NDC: | 59572-205-97 |
| Package Description: | 10 BLISTER PACK in 1 BOX (59572-205-97) > 1 CAPSULE in 1 BLISTER PACK (59572-205-17) |
NDC Information of Thalomid
| NDC Code | 59572-205-97 |
| Proprietary Name | Thalomid |
| Package Description | 10 BLISTER PACK in 1 BOX (59572-205-97) > 1 CAPSULE in 1 BLISTER PACK (59572-205-17) |
| Product NDC | 59572-205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Thalidomide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030620 |
| Marketing Category Name | NDA |
| Labeler Name | Celgene Corporation |
| Substance Name | THALIDOMIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Immunologically Active Molecule Activity [PE] |
